Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-'alfa' in lung cancer (2008)

  • Authors:
  • USP affiliated authors: BARBUTO, JOSE ALEXANDRE MARZAGAO - ICB
  • USP Schools: ICB
  • DOI: 10.1007/s00262-008-0468-7
  • Subjects: IMUNOLOGIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s00262-008-0468-7 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Cancer Immunology, Immunotherapy

    ISSN: 0340-7004

    Citescore - 2017: 4.54

    SJR - 2017: 1.899

    SNIP - 2017: 0.99


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    ICB12100021917PC-ICB BMI SEP 2008
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BALEEIRO, R. B.; ANSELMO, L. B.; SOARES, F. A.; et al. High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-'alfa' in lung cancer. Cancer Immunology and Immunotherapy, New York, v. 57, n. 9, p. 1335-1345, 2008. DOI: 10.1007/s00262-008-0468-7.
    • APA

      Baleeiro, R. B., Anselmo, L. B., Soares, F. A., Pinto, C. A. L., Ramos, O., Gross, J. L., et al. (2008). High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-'alfa' in lung cancer. Cancer Immunology and Immunotherapy, 57( 9), 1335-1345. doi:10.1007/s00262-008-0468-7
    • NLM

      Baleeiro RB, Anselmo LB, Soares FA, Pinto CAL, Ramos O, Gross JL, Haddad F, Younes RN, Tomiyoshi MY, Bergami-Santos PC, Barbuto JAM. High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-'alfa' in lung cancer. Cancer Immunology and Immunotherapy. 2008 ; 57( 9): 1335-1345.
    • Vancouver

      Baleeiro RB, Anselmo LB, Soares FA, Pinto CAL, Ramos O, Gross JL, Haddad F, Younes RN, Tomiyoshi MY, Bergami-Santos PC, Barbuto JAM. High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-'alfa' in lung cancer. Cancer Immunology and Immunotherapy. 2008 ; 57( 9): 1335-1345.

    Referências citadas na obra
    Parkin DM, Bray F, Ferlay J (2005) Global cancer statistics 2002 CA Cancer J Clin 55:74–108
    O’ Mahony D, Kummar S, Gutierrez ME (2005) Non-small-cell lung cancer vaccine therapy: a concise review. J Clin Oncol 23:1–7
    Anselmo LB, Gross JL, Haddad F, Deheinzelin D, Younes R, Barbuto JAM (2005) Functional analysis of cells obtained from bronchoalveolar lavage fluid (BALF) of lung cancer patients. Life Sci 76:2945–2951
    Anselmo LB, Gross JL, Haddad F, Silva RA, Couto WJ, Deheinzelin WD, Younes RN, AB’Saber AM, Canzian M, Capelozzi VL, Barbuto JAM (2005) Dendritic cell distribution in primary lung cancer patients. Keystone Symposia/Basic Aspects of Tumor Immunology, 2005
    Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245–252
    Steinman RM, Cohn ZA (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137:1142–1162
    Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA (2001) Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. J Exp Med 193:51–60
    Zhou LJ, Schwarting R, Smith HM, Tedder TF (1992) A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149:735–742
    Egner W & Hart DN (1995) The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells: possible heterogeneity in bone marrow dendritic cell populations. Immunology 85:611–620
    Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, Julkunen I, Forster R, Burgstahler R, Lipp M, Lanzavecchia A (1999) Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 29:1617–1625
    Gottfried E, Kreutz M, Mackensen A (2007) Tumor-induced modulation of dendritic cell function. Cytokine Growth Factor Rev (in press)
    Doyle A, Martin WJ, Funa K, Gazdar A, Camey D, Martin SE, Linnoila I, Cuttitta F, Mulshine J, Bunn P, Minna J. (1985) Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small cell lung cancer. J Exp Med 161:1135–1154
    Porta C, Bonomi L, Lillaz B, Paglino, Rovati B, Imarisio I, Morbini P (2007) Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells. Anticancer Res 27:165–173
    Fricke I, Gabrilovich DI (2006) Dendritic cells and tumor microenvironment: a dangerous liaison. Immunol Invest 35:459–483
    Chaux P, Moutet M, Faivre J, Martin F, Martin M (1996) Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7–1 and B7-2 costimulatory molecules of T-cell activation. Lab Invest 74:975–983
    Aloysius MM, Takhar A, Robins A, Eremin O (2006) Dendritic cell biology, dysfunction and immunotherapy in gastrointestinal cancers. Surgeon 4:195–210
    Zou W (2005) Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nature Rev Cancer 5:263–273
    Neves AR, Ensina LF, Anselmo LB, Leite KR, Buzaid AC, Camara-Lopes LH, Barbuto JAM (2005) Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferom-gamma in mixed lymphocyte reactions. Cancer Immunol Immunother 54:61–66
    Sallusto P, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 179:1109–1118
    Zhou LJ & Tedder TF (1996) CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 93:2588–2592
    Tazi A, Bouchonnet F, Grandsaigne M, Bounsell L, Hance AJ, Soler P (1993) Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest 91:566–576
    Ogawa E, Takenaka K, Yanagihara K, Kurozumi M, Manabe T, Wada H, Tanaka F (2004) Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. Br J Cancer 91:498–503
    Schafer BW, Heizmann CW (1996) The S100 family of EF-hand calcium-binding proteins: Functions and pathology. Trends Biochem Sci 21:134–140
    Mc Nutt NS (1998) The S100 family of multipurpose calcium-binding proteins. J Cutan Pathol 25:521–529
    Steinman RM, Pack M, Inaba K (1997) Dendritic cells in the T cell areas of lymphoid organs. Immunol Rev 156:25–37
    Takahashi K, Isobe T, Ohtsuki Y, Akagi T, Sonobe H, Okuyama T (1984) Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissues. Virchows Arch B Cell Pathol Incl Mol Pathol 45:385–396
    Nakano T, Oka K, Arai T, Morita S, Tsunemoto H (1989) Prognostic significance of Langerhans` cells infiltration in radiation therapy for squamous cell carcinoma of the uterine cervix. Arch Pathol Lab Med 113:507–511
    Huang JA, Huang HD, Peng QB, Zhu ZJ, Yu XR (1990) S100 protein positive dendritic cells and the significance of their density in gastric precancerous lesions. Proc Chin Acad Med Sci Peking Union Med Coll 5:93–96
    Tsujitani S, Kakeji Y, Watanabe A, Kohnoe S, Maehara Y, Sugimaghi K (1992) Infiltration of S-100 protein positive dendritic cells and peritoneal recurrence in advanced gastric cancer. Int Surg 77:238–241
    Inoue K, Furihata M, Ohtsuki Y, Fujita Y (1993) Distribution of S-100 protein-positive dendritic cells and the expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis. Virchows Arch A Pathol Anat Histophatol 422:351–355
    Sallusto F (2001) Origin and migratory properties of dendritic cells in the skin. Curr Opin Allergy Clin Immunol 1:441–448
    Romani N, Holzmann S, Tripp CH, Koch F, Stoitzner P (2003) Langerhans cells —dendritic cells of the epidermis. APMIS 111:725–740
    Demedts IK, Brusselle GG, Vermaelen KY, Pauwels RA (2005) Identification and characterization of human pulmonary dendritic cells. Am J Respir Cell Mol Biol 32:177–184
    Tataroglu C, Kargi A Özkal S, Esrefoglu N, Akkoçlu A (2004) Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC). Lung Cancer 43:47–54
    Kurabayashi A, Furihata M, Matsumoto M, Hayashi H, Ohtsuki Y (2004) Distribution of tumor-infiltrating dendritic cells in human non-small cell lung carcinoma in relation to apoptosis. Pathol Int 54:302–310
    Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S, Valladeau, Davoust J, Pallucka KA, Banchereau J (1999) In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 190:1417–1426
    Goillot E, Combaret V, Landenstein R, Baubet D, Blay JY, Philip T, Favrot MC (1992) Tumor necrosis factor as an autocrine growth factor for neuroblastoma. Cancer Res 52:3194–3200
    Naylor MS, Stamp GW, Foulkes WD, Eccles D, Balkwill FR (1993) Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest 91:2194–2206
    Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, Balkwill FR (1994) Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue. Int J Cancer 56:777–786
    Iwamoto M, Shinohara H, Miyamoto A, Okusawa M, Mabuchi H, Nohara T, Gon G, Toyoda M, Tanigawa N (2003) Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 104:92–97
    Barbuto JAM, Grimes WJ, Hersh EM (1995) Antibodies to tumor necrosis factor: a component of B cell immune responses with a role in tumor/host interaction. Cancer Immunol Immunother 40:31–36
    Staal-Van Den Brekel AJ, Dentener MA, Drent M, Ten Velde GPM, Buurman WA, Wouters EFM (1998) The enhanced inflammatory response in non-small cell lung carcinoma is not reflected in the alveolar compartment. Respir Med 92:76–83
    Tran TA, Kallakury BVS, Ambros RA, Ross J (1998) Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma. Cancer 83:276–282
    Naylor MS, Stamp GW, Balkwill FR (1990) Investigation of cytokine gene expression in human colorectal cancer. Cancer Res 50:4436–4440
    Ito A, Sato T, Iga T, Mori Y (1990) Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett 269:93–95
    Gordon SB, Read RC (2002) Macrophage defenses against respiratory tract infections. British Med Bull 61:45–61
    Baleeiro RB, Bergami-Santos PC, Tomiyoshi MY, Gross JL, Haddad F, Pinto CAL, Soares FA, Younes RN, Barbuto JAM (2008) Expression of a dendritic cell maturation marker CD83 on tumor from lung cancer patients and several human tumor cell lines: is there a biological meaning behind it? Cancer immunol Immunother 57:265–270